COMMUNIQUÉS West-GlobeNewswire

AxoGen, Inc. Reports 2017 Fourth Quarter and Full Year Financial Results

28/02/2018 - 22:01

Record Q4 Revenue of $17.0 million, representing 49% growth over prior year Record Full year 2017 Revenue of $60.4 million, representing 47% growth over prior year ALACHUA, Fla., Feb. 28, 2018 (GLOBE NEWSWIRE) -- AxoGen [...]

Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance

28/02/2018 - 22:01

Q4 2017 worldwide revenue of $190.9 million ($188.2 million on a comparable, constant currency* basis), up 21.0% as reported (up 19.3% on a comparable, constant currency* basis) over Q4 2016 FY 2017 worldwide revenue of [...]

University of Missouri Health Care Selects Cerner for Revenue Cycle Management

28/02/2018 - 22:01

KANSAS CITY, Mo., Feb. 28, 2018 (GLOBE NEWSWIRE) -- University of Missouri Health Care, in Columbia, has selected Cerner, a global leader in health care technology, to help manage revenue cycle performance across its [...]

Helsinn Files Petition for Writ of Certiorari for Supreme Court Review Regarding Patent Covering Aloxi® in the US Market

28/02/2018 - 21:14

Helsinn Files Petition for Writ of Certiorari for Supreme Court Review Regarding Patent Covering Aloxi® in the US Market Lugano, Switzerland, and Woodcliff Lake, N.J., February 28, 2018 - In response to the United [...]

Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido™ (lidocaine topical system) 1.8% for PHN Pain

28/02/2018 - 20:12

SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) (“Sorrento”), and its majority-owned subsidiary, Scilex Pharmaceuticals Inc. (“Scilex”), received approval from the U.S. Food and [...]

Eloxx Pharmaceuticals Appoints Biotech Leader, Dr. Jasbir Seehra, Co-founder of Acceleron Pharma, to Board of Directors

28/02/2018 - 19:01

WALTHAM, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”), (ELOX) (Other OTC: SVOND ) a clinical-stage biopharmaceutical company developing novel read-through drug candidates that are [...]

UPDATE - Market for analytical and life science instruments projected to grow by 4.6%

28/02/2018 - 18:57

LOS ANGELES, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Strategic Directions International (SDi), a division of BioInformatics Inc., today announced the release of the SDi Global Assessment Report 2018: The Laboratory Analytical [...]

PDC Healthcare Launches New TimeAlert™ IV Time-Indicating Reminder Labels to Show Time Lapse for IV Tubing

28/02/2018 - 18:55

VALENCIA, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- PDC Healthcare , a global leader of innovative identification and patient safety solutions, announced today it has added TimeAlert™ IV time-indicating reminder labels [...]

Capital Increase in Genmab as a Result of Employee Warrant Exercise

28/02/2018 - 18:31

Company Announcement Copenhagen, Denmark; February 28, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 65,419 shares as a consequence of the exercise of employee warrants. The increase is [...]

NÉOVACS RENFORCE SA STRUCTURE FINANCIÈRE À HAUTEUR DE 1 M€ PAR PLACEMENT PRIVÉ ET À HAUTEUR DE 3,8 M€ PAR UNE ÉMISSION OBLIGATAIRE CONVERTIBLE

28/02/2018 - 18:01

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS RENFORCE SA STRUCTURE FINANCI È RE À HAUTEUR DE 1 M€ PAR PLACEMENT PRIV É ET À HAUTEUR DE 3,8 M€ PAR UNE É MISSION OBLIGATAIRE CONVERTIBLE Paris [...]

OSE Immunotherapeutics Presenting at the Annual International Conference BIO-EUROPE SPRING®

28/02/2018 - 18:00

Amsterdam, March 12-14, 2018 NANTES, France, Feb. 28, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), announces it will be featured as a presenting company at the 12th Annual Conference [...]

Bringing Intelligence to Heart Sounds, Eko Closes $5 Million Series A Led by ARTIS Ventures

28/02/2018 - 18:00

Berkeley, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Eko , the leader in acoustic cardiac monitoring, today announced a $5 million Series A led by ARTIS Ventures . Additional investors in the round include Strategic Partners, [...]

Market for analytical and life science instruments projected to grow by 4.6%

28/02/2018 - 17:23

LOS ANGELES, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Strategic Directions International (SDi), a division of BioInformatics LLC, today announced the release of the 2018 Global Assessment Report: The Laboratory Analytical [...]

Consolidated Sales of Olainfarm Reached 122 Million Euros

28/02/2018 - 17:15

Olaine, 2018-02-28 17:15 CET (GLOBE NEWSWIRE) -- “Successful operations of the Company in future will largely depend on its ability to diversify its sales markets and products and to preserve its current position in its [...]

Metabolon Launches Meta UDx™ Test to Speed Diagnosis of Rare and Undiagnosed Diseases in Children and Adults

28/02/2018 - 16:50

Meta UDx provides in-depth metabolic information and new insights for difficult-to-diagnose patient cases Expanding LDT clinical testing portfolio demonstrates value of clinical metabolomics for rare and undiagnosed [...]

Tabula Rasa HealthCare to Announce Fourth Quarter and Full Year 2017 Operating Results and Host Conference Call on Monday, March 12, 2018

28/02/2018 - 16:00

MOORESTOWN, N.J., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software [...]

Client Outlook Announces Partnership with InTouch Health to Deliver Next Generation Telehealth Image Viewing Solution

28/02/2018 - 16:00

WATERLOO, Ontario, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Client Outlook, leading developer of healthcare imaging solutions, announced today the planned integration of its eUnity diagnostic and clinical image viewing [...]

Endocyte Announces Pricing of Public Offering of Common Stock

28/02/2018 - 15:18

WEST LAFAYETTE, Ind., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq Global Market:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, announced today the [...]

Predictive Technology Group, Inc. (PRED) Retains Donohoe Advisory Associates, LLC to Assist in Preparing to Seek a Listing on a National Securities Exchange

28/02/2018 - 15:15

SALT LAKE CITY, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCPINK:PRED) announces that it has engaged Donohoe Advisory Associates , LLC (“Donohoe Advisory”) in connection with its efforts to [...]